维普中文期刊产品整合服务
98篇 您的检索式:作者名="Bojunga"
    题名 作者 年代 出处 被引量
1Intraductal endoscopic radiofrequency ablation for the treatment of hilar non-resectable malignant bile duct obstruction显示文摘AIM: To evaluate the safety and technical success of endoscopic radiofrequency ablation(RFA) for palliative treatment of malignant hilar bile duct obstruction. METHODS: In this study, a recently CE and FDA-approved endoscopic RFA catheter was first tested in an ex vivo pig liver model to study the effect of electrosurgical variables on the extent of the area of induced necrosis. Subsequently, a retrospective analysis was conducted of all patients treated with endoscopic RFA for malignant biliary obstruction at our center between February 2012 and April 2013. All patients received an additional plastic stent implantation into the biliary tree following RFA. RESULTS: In the pig model, ablation time of 60-90 seconds using the bipolar soft coagulation mode at 8-10 watts with an effect of 8 was found to be the most feasible setting. Twelve patients(5 females, 7 males; mean age, 70 years) underwent 19 endoscopic RFA(range, 1-5) sessions. Deployment of RFA was successful in all patients. Systemic chemotherapy was administered in four patients. We observed biliary bleeding 4-6 wk after the intervention in three cases and two of these patients died: in one patient, spontaneous hemobilia occurred, whereas bleeding started during stent extraction in the other. In the third patient, bleeding was stopped by insertion of a non-covered self-expanding metal stent. Another three patients developed cholangitis during follow-up. Seven patients died during follow-up and median survival was 6.4 mo(95%CI: 0.05-12.7) from the time of the first RFA. CONCLUSION: Endoscopic RFA is an easy to perform and technically highly successful procedure. However, hemobilia possibly associated with RFA occurred in three of our patients. Therefore, larger prospective studies are needed to further evaluate the safety and efficacy of this promising new method.Andrea Oliver Tal Johannes Vermehren Mireen FriedrichRust Jrg Bojunga Christoph Sarrazin Stefan Zeuzem Jrg Trojan Jrg Gerhard Albert 2014World Journal of Gastrointestinal Endoscopy2014,6,1:18
2Performance of Transient Elastography for the Staging of Liver Fibrosis: A Meta-Analysis显示文摘Mireen Friedrich–Rust Mei–Fang Ong Swantje Martens Christoph Sarrazin Joerg Bojunga Stefan Zeuzem Eva Herrmann 2008Gastroenterology2008,,4:6
3Influence of antibiotic-regimens on intensive-care unit-mortality and liver-cirrhosis as risk factor显示文摘AIM: To assess the rate of infection, appropriateness of antimicrobial-therapy and mortality on intensive care unit(ICU). Special focus was drawn on patients with liver cirrhosis.METHODS: The study was approved by the local ethical committee. All patients admitted to the Internal Medicine-ICU between April 1, 2007 and December 31, 2009 were included. Data were extracted retrospectively from all patients using patient charts and electronic documentations on infection, microbiological laboratory reports, diagnosis and therapy. Due to the large hepatology department and liver transplantation center, special interest was on the subgroup of patients with liver cirrhosis. The primary statistical-endpoint was the evaluation of the influence of appropriate versusinappropriate antimicrobial-therapy on in-hospitalmortality.RESULTS: Charts of 1979 patients were available. The overall infection-rate was 53%. Multiresistantbacteria were present in 23% of patients with infection and were associated with increased mortality(p < 0.000001). patients with infection had significantly increased in-hospital-mortality(34% vs 17%, p < 0.000001). Only 9% of patients with infection received inappropriate initial antimicrobial-therapy, no influence on mortality was observed. Independent risk-factors for in-hospital-mortality were the presence of septicshock, prior chemotherapy for malignoma and infection with pseudomonas spp. Infection and mortality-rate among 175 patients with liver-cirrhosis was significantly higher than in patients without liver-cirrhosis. Infection increased mortality 2.24-fold in patients with cirrhosis. patients with liver cirrhosis were at an increased risk to receive inappropriate initial antimicrobial therapy.CONCLUSION: The results of the present study report the successful implementation of early-goal-directed therapy. Liver cirrhosis patients are at increased risk of infection, mortality and to receive inappropriate therapy. Increasing burden are multiresistant-bacteria.Mireen Friedrich-Rust Beate Wanger Florian Heupel Natalie Filmann Reinhard Brodt Volkhard AJ Kempf Johanna Kessel Thomas A Wichelhaus Eva Herrmann Stefan Zeuzem Joerg Bojunga 2016World Journal of Gastroenterology2016,22,16:6
4Contrast‐Enhanced Ultrasound for the differentiation of benign and malignant focal liver lesions: a meta‐analysis显示文摘Mireen Friedrich‐Rust Tom Klopffleisch Julia Nierhoff Eva Herrmann Johannes Vermehren Maximilian D. Schneider Stefan Zeuzem Joerg Bojunga 2013Liver Int2013,,5:3
5EFSUMB Guidelines and Recommendations on the Clinical Use of Ultrasound Elastography. Part 1: Basic Principles and Technology显示文摘J. Bamber D. Cosgrove C. Dietrich J. Fromageau J. Bojunga F. Calliada V. Cantisani J.-M. Correas M. D’Onofrio E. Drakonaki M. Fink M. Friedrich-Rust O. Gilja R. Havre C. Jenssen A. Klauser R. Ohlinger A. Saftoiu F. Schaefer I. Sporea F. Piscaglia 2013Ultraschall in Med2013,,02:2
6Real-time elastography for the differen- tiation of benign and malignant thyroid nodule 显示文摘Bojunga J Herrmann E 2010Thyroid2010,20,:1
7Real-time elastography for the differentiation of benign and malignant thyroid nodules: a meta-analysis 显示文摘Bojunga J Herrmann E Meyer G 2010Thyroid2010,20,10:1
8Severe lactic acidosis during treatment of chronic hepatitis B with entecavir in patients with impaired liver function 显示文摘Lange CM Bojunga J Hofmann WP 2009Hepatology2009,50,6:1
9Detection of thyroid peroxidase mRNA in peripheral blood of patients with malignant and benign thyroid diseases显示文摘Roddiger S J Bojunga J Klee V 2002Mol Endocrinol2002,29,3:1
10Urapidil in the preoperative treat-ment of pheochromocytomas: a safe and cost - effective method 显示文摘Habbe N Ruger F Bojunga J 2013World J Surg2013,37,5:1
11Acoustic radiation forceimpulse imaging for differentiation of thyroid nodules显示文摘Bojunga J Dauth N Berner C 2012PLoS One2012,7,42:1
12Realtime elastogra phy for the differentiation of benign and malignant thyroid nodules: ameta-analysis 显示文摘Bojunga J HerrmannE Meyer G 2010Thyroid2010,20,10:1
13Detection of thyroid peroxidase mRNA in peripheral blood of patients with malignant and benign thyroid diseases 显示文摘 Bojunga J Klee V 2002Mol Endocrinol2002,29,3:1
14Antioxidative treatment prevents activation of death-receptor-and mitochondrion-dependent apoptosis in the hearts of diabetic rats显示文摘Bojunga J Nowak D Mitrou PS 2004Diabetologia2004,47,12:1
15Severe 25‐hydroxyvitamin D deficiency identifies a poor prognosis in patients with hepatocellular carcinoma – a prospective cohort study显示文摘F. Finkelmeier B. Kronenberger V. K?berle J. Bojunga S. Zeuzem J. Trojan A. Piiper O. Waidmann 2014Aliment Pharmacol Ther2014,,10:1
16Differential effects of short-term lipid lowering with Ezetimibe and statins on endothelial function in patients with CAD: Clinical evidence for pleiotropic functions of statin therapy显示文摘Fichtlscherer Schmidt-Lucke C Bojunga S 2006Eur Heart J2006,27,10:1
17Real-time elastography for the differentiation of benign and malignant thyroid nodules : a meta-analysis显示文摘BOJUNGA J HERRMANN E MEYER G 2010Thyroid2010,20,10:1
18Real-time elastography for the differentiation of benign and malignant thyroid nodules:ameta-analysis显示文摘Bojunga J Herrmann E Meyer G 2010Thyroid2010,20,10:1
19Antioxidative treat- ment prevents activation of death-receptor- and mitoehondrion- dependent apoptosis in the hearts of diabetic rats 显示文摘Bojunga J Nowak D Mitrou P S 2004Dia-betologia2004,47,12:1
20Se- vere lactic acidosis during treatment of chronic hepatitis B with enteeavir in patients with impaired liver function 显示文摘LANGE C M BOJUNGA J HOFMANN W P 2009Hepatology2009,50,6:1
返回顶部 每页显示:
共5页 首页 上一页 第1页 下一页 末页 /5 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费